Patients with symptomatic (New York Heart Association [NYHA] class III or IV) systolic (left ventricular ejection fraction [LVEF] ≤40%) congestive heart failure (CHF) were randomized to ...
Since most of the clinical trials of -blocking agents have been conducted in patients with heart failure NYHA functional class II/III, until recently there was limited information regarding safety ...
In the subgroup of patients with NYHA class III heart failure, there was a relative 44% increase in the risk of death among patients receiving amiodarone compared with placebo. 9 Such a finding ...
symptoms of NYHA class 3–4 heart failure, and low ejection fraction associated with mild left ventricular dilation, among other signs of heart dysfunction. Transmission electron micrographs of ...